Reuters logo
BRIEF-Imprimis Pharmaceuticals to offer compounded Cyclosporine alternative to Restasis
October 19, 2017 / 11:57 AM / a month ago

BRIEF-Imprimis Pharmaceuticals to offer compounded Cyclosporine alternative to Restasis

Oct 19 (Reuters) - Imprimis Pharmaceuticals Inc

* Imprimis Pharmaceuticals-‍making compounded Cyclosporine-based formulations available for physicians to consider prescribing as alternatives to Restasis​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below